Altria Shares Priced Below Industry Average: Should You Buy or Hold?
Valuation and Performance: Altria Group, Inc. (MO) is currently trading at a forward P/E ratio of 10.46, which is below industry averages, indicating a potential buying opportunity. The stock has shown steady momentum, rising 1.1% over the past month, outperforming some competitors while the broader market has seen slight declines.
Financial Fundamentals: Altria's financial health is supported by resilient earnings growth, with a 3.6% increase in adjusted EPS in Q3 2025. The company maintains strong profitability in its smokeable products segment, particularly with its Marlboro brand, which has expanded its market share.
Strategic Initiatives: Altria is focusing on long-term growth through collaborations, such as with KT&G, to expand its product offerings and operational efficiencies. The company is also enhancing its oral tobacco portfolio, particularly with the on! brand, to capture growth in the nicotine pouch market.
Market Challenges: Despite its strengths, Altria faces significant volume pressures in both smokeable and oral categories, with cigarette shipments declining. The rise of unregulated flavored disposable e-vapor products adds competitive pressure, making it essential for investors to remain cautious about evolving market dynamics.
Trade with 70% Backtested Accuracy
Analyst Views on PM
About PM
About the author

- Sector Performance: In 2026, the consumer staples sector has surged over 15.5% in the S&P 500, becoming the third-best performing sector, indicating a growing investor preference for defensive stocks amid a market rotation.
- Valuation Surge: Wolfe Research noted that market-weighted valuations for consumer staples have reached their highest levels since the 1990s, reflecting increased investor confidence in the sector despite a lackluster overall market performance.
- Walmart's Market Position: Walmart's stock jumped 20% in 2026, allowing it to join the $1 trillion market cap club, showcasing its adaptability in the AI economy and solidifying its leading position in retail.
- Future Outlook: Analysts predict that as consumer demand rebounds in 2026, the fundamentals for the consumer staples sector are likely to improve, particularly with potential tax relief for lower-income households boosting product demand.
- Teva's Positive Outlook: Goldman Sachs analysts assert that despite Teva's stock doubling over the past year, its current valuation remains attractive, and the company is on a rapidly ascending earnings trajectory, urging investors to remain calm and accumulate shares.
- Philip Morris's Successful Transformation: Goldman highlights that Philip Morris is transforming into a faster-growing and more profitable business, with shares up nearly 18% year-to-date, indicating significant upside potential as it delivers strong earnings growth.
- S&P Global's Strong Positioning: Although S&P Global's stock has declined 22% this year, analysts believe its strong AI positioning and durable long-term earnings power will drive organic revenue growth, with a revised price target lowered from $555 to $498.
- Nvidia's Market Focus: Goldman expects Nvidia to report strong results in its upcoming earnings, with investors keenly watching for insights into 2027 visibility and competitive dynamics, despite high expectations for outperformance.
- Price Range Analysis: UPRO ETF's 52-week low is $45.88 per share and high is $122.85, with the last trade at $113.91, indicating significant volatility over the past year and reflecting varying market expectations for its future performance.
- Technical Analysis Tool: Comparing the current share price to the 200-day moving average can provide investors with valuable insights for technical analysis, aiding in the assessment of market trends and potential buy or sell opportunities.
- ETF Unit Trading Mechanism: Exchange-traded funds (ETFs) trade similarly to stocks, where investors are buying and selling “units” that can be created or destroyed based on investor demand, impacting the ETF's liquidity and market performance.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding for ETFs helps identify those experiencing notable inflows (new units created) or outflows (old units destroyed), allowing for an assessment of their impact on underlying assets and shifts in market sentiment.
- Ban Impacts Expansion: India's steadfast ban on e-cigarettes and heat-not-burn tobacco products has significantly hindered Philip Morris International's plans to launch IQOS in the Indian market, despite years of lobbying efforts.
- Unrealized Market Potential: Although India ranks as the seventh-largest cigarette market globally, Philip Morris executives discussed the long-term value creation potential of IQOS with state officials at Davos, but failed to secure an exemption, highlighting market resistance.
- Growth in Smoke-Free Products: Since 2014, Philip Morris's smoke-free products have attracted over 35 million users, with sales from 27 markets now accounting for over 50% of total revenue, indicating strong momentum in other markets.
- Strong Financial Performance: In fiscal 2025, Philip Morris's cigarette and heated tobacco unit shipment volume rose 1.7% to 379.6 billion units, with India contributing a remarkable 39.2% growth, showcasing the potential market opportunities in the region.
- Conference Schedule: Philip Morris International will host a live audio webcast on February 18, 2026, at 10:00 AM ET during the CAGNY Conference, featuring Group CEO Jacek Olczak and CFO Emmanuel Babeau, which is expected to attract significant attention from investors and analysts.
- Portfolio Transformation: The company is committed to delivering a smoke-free future, with its current product portfolio including heat-not-burn, nicotine pouches, and e-vapor products, and by the end of 2025, over 43 million legal-age consumers globally are expected to use these smoke-free products, indicating a gradual shift away from traditional cigarettes.
- Revenue Contribution: As of 2025, the smoke-free business accounted for 41.5% of total net revenues, demonstrating significant financial achievements during the transformation process and laying a solid foundation for future growth.
- R&D Investment: Since 2008, Philip Morris has invested over $16 billion in developing and commercializing innovative smoke-free products, showcasing its strong capabilities in scientific assessment and market research, with the aim of completely ending cigarette sales.
- Tobacco Product Growth: Philip Morris's smoke-free portfolio continued to drive performance in Q4, with Zyn nicotine pouch shipments rising 18% year-over-year and 20% in the U.S., indicating strong consumer demand for innovative tobacco products and further solidifying the company's market position in the tobacco industry.
- Robust Financial Performance: The company reported a 3.7% year-over-year organic revenue increase to $10.4 billion in Q4, with overall revenue climbing 6.8% and adjusted EPS rising 9.4% to $1.70, reflecting resilience and profitability amid market challenges.
- Positive Future Outlook: Philip Morris forecasts organic revenue growth of 5% to 7% in 2026, despite pressures from declining traditional cigarette volumes, while smoke-free product volumes are expected to rise by high single digits, showcasing the company's potential during its transformation.
- Strong Cash Flow Projections: The company anticipates generating $45 billion in operating cash flow over the next three years, with growth expected to accelerate in 2027 due to the end of taxation equalization in Japan for heated tobacco units and the launch of Iqos in the U.S., indicating strategic positioning in new market expansions.









